IndraLab

Statements

EIF4EBP1 inhibits USP15. 1 / 1

| 1

reach

"Pre-treatment with LY294002, an inhibitor of PI3K, or with MK2206, an inhibitor of AKT (XREF_SUPPLEMENTARY), or with rapamycin or RAD001 (XREF_SUPPLEMENTARY), the inhibitor of mTOR, blocked the phosphorylation of 4E-BP1 mediated by the PI3K and AKT pathway, and disrupted upregulation of USP15 synthesis mediated by TGF-beta (XREF_FIG)."

27893708

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

EIF4EBP1 inhibits USP15. 1 / 1

INDRA sources:

Databases

Reading